Published in Gastroenterology on February 01, 1986
Updates in the pathogenesis, diagnosis and management of ectopic varices. Hepatol Int (2008) 1.97
Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg (1993) 1.63
ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol (2015) 1.58
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology (2013) 1.58
Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol (2010) 1.08
Primary sclerosing cholangitis: diagnosis, prognosis, and management. Clin Gastroenterol Hepatol (2013) 0.98
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol (2015) 0.90
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol (2014) 0.88
Transjugular intrahepatic porto-systemic shunt and variceal embolisation in the management of bleeding stomal varices. Int J Colorectal Dis (2005) 0.88
Transjugular portosystemic shunt for treatment of bleeding stomal varices. Dig Dis Sci (1997) 0.86
Ileal conduit stomal variceal bleeding managed by endovascular embolization. World J Gastroenterol (2013) 0.83
Ectopic varices in colonic stoma: MDCT findings. Korean J Radiol (2006) 0.82
Management of parastomal varices: who re-bleeds and who does not? A systematic review of the literature. Tech Coloproctol (2012) 0.81
Bleeding stomal varices: a marker of chronic liver disease. BMJ Case Rep (2009) 0.79
Liver metastases, a rare cause of portal hypertension and stoma bleeding. Brief review of literature. Int J Surg Case Rep (2012) 0.79
Peristomal varices--life threatening or luminal? Ann R Coll Surg Engl (2006) 0.78
Restorative proctocolectomy and pouch anal anastomosis for ulcerative colitis following orthotopic liver transplantation. Gut (1995) 0.77
Bleeding from peristomal varices: a complication of portal hypertension. BMJ Case Rep (2011) 0.75
Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol (2013) 0.75
Primary Sclerosing Cholangitis: Current and Future Management Strategies. Curr Hepat Rep (2013) 0.75
Patients, cells, and organelles: the intersection of science and serendipity. Hepatology (2011) 0.75
Recurrent bleeding from cutaneous venous collaterals in portal hypertension. Gut (1988) 0.75
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Biliary tract cancers. N Engl J Med (1999) 6.36
Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology (1980) 3.57
Vascular complications of inflammatory bowel disease. Mayo Clin Proc (1986) 3.00
Ileal pouch-anal anastomosis for chronic ulcerative colitis. Long-term results. Ann Surg (1987) 2.98
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology (1998) 2.75
Outcome of "indeterminant" colitis following ileal pouch-anal anastomosis. Dis Colon Rectum (1989) 2.41
Leiomyosarcoma of the small and large bowel. Cancer (1978) 2.39
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res (2000) 2.38
Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med (1997) 2.38
Current concepts. Primary sclerosing cholangitis. N Engl J Med (1984) 2.35
Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl (2000) 2.27
The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol (2000) 2.25
Ileal "J" pouch-anal anastomosis. Clinical outcome. Ann Surg (1985) 2.16
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg (1998) 2.15
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology (1994) 2.10
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest (1990) 1.99
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc (1989) 1.93
Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg (1990) 1.93
Restorative proctocolectomy with ileal reservoir. Int J Colorectal Dis (1986) 1.91
Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. Gastroenterology (1989) 1.89
Effect of distal antrectomy on gastric emptying of liquids and solids. Gastroenterology (1971) 1.89
Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology (1982) 1.88
Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant (2008) 1.86
Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application. Gastroenterology (1980) 1.84
Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum (1999) 1.79
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Surgical treatment of adenocarcinoma of the rectum. Ann Surg (1998) 1.77
Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology (1996) 1.76
Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology (1990) 1.76
A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis (1995) 1.71
Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc (1988) 1.71
Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J Hepatol (2000) 1.70
Detection of cytomegalovirus DNA in sera of liver transplant recipients. J Clin Microbiol (1994) 1.69
Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology (1990) 1.69
Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol (1998) 1.68
The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg (1997) 1.68
Temporary ileostomy for ileal pouch-anal anastomosis. Function and complications. Dis Colon Rectum (1986) 1.67
Straight ileoanal anastomosis v ileal pouch--anal anastomosis after colectomy and mucosal proctectomy. Arch Surg (1983) 1.63
Recent advances in the isolation of liver cells. Hepatology (1994) 1.63
Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg (1993) 1.63
Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc (1993) 1.59
Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc (1995) 1.59
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc (1994) 1.59
Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption. N Engl J Med (1974) 1.58
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant (2014) 1.57
Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations. N Engl J Med (1985) 1.57
Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells. Lab Invest (1996) 1.56
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54
Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology (1993) 1.53
Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol (2001) 1.52
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
A clinico-physiological comparison of ileal pouch-anal and straight ileoanal anastomoses. Ann Surg (1983) 1.50
Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology (1983) 1.49
Bleeding from cavernous angiomatosis of the rectum in Klippel-Trenaunay syndrome: report of three cases and literature review. Am J Gastroenterol (2001) 1.49
Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology (1999) 1.49
Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol (1997) 1.47
Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem (1992) 1.47
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc (2000) 1.45
Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation (1996) 1.44
Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol (1997) 1.44
Prognosis of symptomatic duodenal adenomas in familial adenomatous polyposis. Arch Surg (1991) 1.44
Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg (2007) 1.44
The autologous mixed lymphocyte reaction in primary biliary cirrhosis: analysis of activation and blastogenesis of autoreactive T lymphocytes. Hepatology (1988) 1.43
Retracted Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology (1992) 1.43
Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc (1994) 1.43
The Peutz-Jeghers syndrome. Is there a predisposition to the development of intestinal malignancy? Arch Surg (1969) 1.42
Nutritional support for liver transplantation: identifying caloric and protein requirements. Mayo Clin Proc (1994) 1.42
Anal and neorectal function after ileal pouch-anal anastomosis. Ann Surg (1986) 1.42
Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut (1975) 1.41
Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest (2001) 1.40
The role of portosystemic shunts for variceal bleeding in the liver transplantation era. Arch Surg (1994) 1.40
Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology (2001) 1.40
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol (2000) 1.40
Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis (1995) 1.39
A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation. Kidney Int (2007) 1.38
Surreptitious use of salicylates: a cause of chronic recurrent gastroduodenal ulcers. Mayo Clin Proc (1988) 1.38